Login

Brian Cox, CEO of SurgePays, Inc., discusses current $SURG developments at the technology and telecommunications company. 00:10:00

Share On Facebook Share On Twitter

Kevin Brian Cox. Chairman/CEO, SurgePays Inc ;

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Why governments should be run more like tech companies|Adrian Fenty,Managing General Partner,MaC Venture Capital
00:10:00
Understanding Financial Planning and the Gap Analysis Process
00:10:00
Abitare In: A Real Estate Developer Thriving in Milan's Booming Market | Marco Claudio Grillo, Founder, AbitareIn
00:10:00
Insights into Current Trends and Opportunities in the Global Mining Market
00:10:00
Merdeka Copper and Gold: Expanding Operations in Indonesia's Resource-Rich Landscape
00:10:00
Granada Gold Project - Near-Term Production and Growth Potential
00:00:00
Faron Pharmaceuticals outlines groundbreaking work in cancer treatment - Markku Jalkanen, CEO of Faron Pharmaceuticals Limited
00:10:00
Diversey IPO Preview with CEO Phil Wieland | Phil Wieland - CEO of Diversey Holdings
00:10:00
Challenges in U.S. Talent Acquisition: Beat Wittmann on European Investment Banks | Chairman, Porta Advisors
00:10:00
Sarama Resources' Strategic Plans and Investment Potential in 2020: Insights from the CEO at Cape Town Mining Conference
00:10:00
Pandemic Perspectives: Cargojet CEO's Supply Chain Insights | Dr. Ajay K. Virmani - CEO of Cargojet
00:00:00
Lab studies how cells translate internal and external signals into decisions such as growth, death / Galit Lahav Novartis Professor of Systems Biology, HMS

© 2017 - Neuhu+